Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac Function.
Kamada H, Ishibashi K, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Takaya Y, Inoue Y, Miyamoto K, Nagase S, Aiba T, Yazaki Y, Isobe M, Terasaki F, Ohishi M, Kusano KF. Kamada H, et al. Among authors: miyamoto k. JACC Asia. 2023 Sep 5;3(5):755-763. doi: 10.1016/j.jacasi.2023.07.006. eCollection 2023 Oct. JACC Asia. 2023. PMID: 38094999 Free PMC article.
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T; EMPA-ICD investigators. Fujiki S, et al. Diabetes Ther. 2020 Nov;11(11):2739-2755. doi: 10.1007/s13300-020-00924-9. Epub 2020 Sep 23. Diabetes Ther. 2020. PMID: 32968947 Free PMC article.
Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases.
Tonegawa-Kuji R, Inoue YY, Nakai M, Kanaoka K, Sumita Y, Miyazaki Y, Wakamiya A, Shimamoto K, Ueda N, Nakajima K, Wada M, Kamakura T, Yamagata K, Ishibashi K, Miyamoto K, Nagase S, Aiba T, Miyamoto Y, Iwanaga Y, Kusano K. Tonegawa-Kuji R, et al. Among authors: miyamoto k, miyamoto y. BMJ Open. 2023 Jan 13;13(1):e068124. doi: 10.1136/bmjopen-2022-068124. BMJ Open. 2023. PMID: 36639209 Free PMC article.
Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope.
Tonegawa-Kuji R, Inoue YY, Nakai M, Kanaoka K, Sumita Y, Miyazaki Y, Wakamiya A, Shimamoto K, Ueda N, Nakajima K, Kataoka N, Wada M, Yamagata K, Ishibashi K, Miyamoto K, Nagase S, Aiba T, Miyamoto Y, Iwanaga Y, Kusano K. Tonegawa-Kuji R, et al. Among authors: miyamoto k, miyamoto y. CJC Open. 2022 Dec 23;5(4):259-267. doi: 10.1016/j.cjco.2022.12.007. eCollection 2023 Apr. CJC Open. 2022. PMID: 37124961 Free PMC article.
Transvenous lead extraction versus surgical lead extraction or conservative treatment for cardiac implantable electronic device infections: Propensity score-weighted analyses of a nationwide claim-based database.
Wada M, Inoue YY, Nakai M, Sumita Y, Tonegawa-Kuji R, Miyazaki Y, Wakamiya A, Shimamoto K, Ueda N, Nakajima K, Kamakura T, Yamagata K, Ishibashi K, Miyamoto K, Nagase S, Aiba T, Iwanaga Y, Miyamoto Y, Kusano K. Wada M, et al. Among authors: miyamoto k, miyamoto y. Pacing Clin Electrophysiol. 2023 Aug;46(8):833-839. doi: 10.1111/pace.14789. Epub 2023 Jul 23. Pacing Clin Electrophysiol. 2023. PMID: 37485704
Implications of ventricular arrhythmia after cardiac resynchronization therapy.
Ueda N, Ishibashi K, Noda T, Oka S, Miyazaki Y, Shimamoto K, Wakamiya A, Nakajima K, Kamakura T, Wada M, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kanzaki H, Izumi C, Noguchi T, Kusano K. Ueda N, et al. Among authors: miyamoto k. Heart Rhythm. 2024 Feb;21(2):163-171. doi: 10.1016/j.hrthm.2023.09.014. Epub 2023 Sep 20. Heart Rhythm. 2024. PMID: 37739199
N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients.
Ueda N, Kataoka N, Miyazaki Y, Shimamoto K, Wakamiya A, Nakajima K, Kamakura T, Wada M, Ishibashi K, Yamagata K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kinugawa K, Minamino N, Kusano K. Ueda N, et al. Among authors: miyamoto k. Int J Cardiol Heart Vasc. 2023 Oct 24;49:101282. doi: 10.1016/j.ijcha.2023.101282. eCollection 2023 Dec. Int J Cardiol Heart Vasc. 2023. PMID: 37908624 Free PMC article.
Maximum burn prevention practice vs conventional care after direct current cardioversion treatment: The BURN-PREVENTION trial.
Tonegawa-Kuji R, Yamagata K, Kanaoka K, Wakamiya A, Inoue YY, Miyamoto K, Miyamoto Y, Kiyohara E, Kusano K. Tonegawa-Kuji R, et al. Among authors: miyamoto k, miyamoto y. Heart Rhythm. 2024 Apr 8:S1547-5271(24)02330-0. doi: 10.1016/j.hrthm.2024.03.1818. Online ahead of print. Heart Rhythm. 2024. PMID: 38599471 No abstract available.
3,506 results